Biotheranostics, Inc.

United States

Hologic's Breast Cancer Index Test Demonstrates Significant Impact on Extended Endocrine Therapy Decisions in Real-World Study

Breast Cancer Index Test Shows Promise for Identifying Low-Risk Premenopausal Patients Who May Avoid Aggressive Therapy